journal article·2017-12-11

Magnetic Resonance Imaging of Alginate Beads Containing Pancreatic Beta Cells and Paramagnetic Nanoparticles

Sary Sarkis, Fanny Silencieux, Karen E. Markwick, Marc-André Fortin, Corinne A. Hoesli

Publisher page

Abstract

Microencapsulation is being investigated as a means to avoid rejection of transplanted pancreatic islets. Monitoring bead distribution and stability in vivo is an important step toward improving microencapsulated islet transplantation strategies. Islet co-encapsulation with gadolinium-labeled mesoporous silica nanoparticles (Gd-MSNs) could allow bead visualization while immobilizing and limiting the potential internalization of the contrast agent. The porous nature of the MSNs could also be used to locally release anti-inflammatory, angiogenic, or anti-apoptotic factors. Mouse insulinoma 6 (MIN6) beta cells were co-encapsulated with Gd-MSNs in alginate beads produced by emulsification and internal gelation. Gd-MSN alginate beads appeared brighter in T 1 -weighted imaging sequences (detection threshold of 0.016 mM Gd; relaxometric ratio r 2 / r 1 = 1.45) than beads without Gd-MSNs. No leaching of Gd 3+ from the hydrogels was detected over the course of 3 months. MIN6 cells co-encapsulated with Gd-MSNs were viable without significant differences in cell growth rate compared to encapsulated controls without Gd-MSNs. This study paves the way for microencapsulated islet tracking via MRI using co-encapsulated paramagnetic nanomaterials.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Pancreatic function and diabetes · Diabetes Management and Research · Diabetes and associated disorders

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical Engineering, McGill University, Wong Building, 3610 University Street, Montreal, QC H3A 0C5, Canada

Laboratoire de Biomatériaux pour l’Imagerie médicale, Axe Médecine Régénératrice, Centre de recherche du Centre hospitalier universitaire de Québec (CR-CHU de Québec), 10 rue de l’Espinay, Québec City, QC G1L 3L5, Canada

Centre de recherche sur les matériaux avancés (CERMA), Université Laval, Pavillon Vachon, 1065 avenue de la Médecine, Québec City, QC G1V 0A6, Canada

Département de Génie des Mines, de la Métallurgie et des Matériaux, Université Laval, Pavillon Pouliot, 1065 avenue de la Médecine, Québec City, QC G1V 0A6, Canada

Funding

Fonds de Recherche du Qu?bec - Sant? · Fonds de Recherche du Qu?bec - Nature et Technologies

References (63)

Show source-provided references
1. 10.1016/S0140-6736(13)60591-710.1016/S0140-6736(13)60591-7 ↗
2. CDC Canadian Diabetes Association 2015 Pre-Budget Submission to the House of Common Standing Committee on Finance;Canadian Diabetes Association:Toronto, ON, 2014; p8.
3. 10.2337/dc12-006310.2337/dc12-0063 ↗
4. 10.2337/diacare.26.12.328810.2337/diacare.26.12.3288 ↗
5. 10.2337/dc15-198810.2337/dc15-1988 ↗
6. 10.1148/rg.30209574110.1148/rg.302095741 ↗
7. 10.1097/01.TP.0000081043.23751.8110.1097/01.TP.0000081043.23751.81 ↗
8. 10.2337/db06-017310.2337/db06-0173 ↗
9. 10.1126/science.677662810.1126/science.6776628 ↗
10. 10.1042/BA2003015110.1042/BA20030151 ↗
11. 10.2337/diabetes.50.8.169810.2337/diabetes.50.8.1698 ↗
12. 10.1097/00007890-199211000-0000110.1097/00007890-199211000-00001 ↗
13. 10.1002/sctm.16-011610.1002/sctm.16-0116 ↗
14. 10.1590/S0004-2803201100020001110.1590/S0004-28032011000200011 ↗
15. 10.1007/s00125-004-1531-310.1007/s00125-004-1531-3 ↗
16. 10.1016/j.addr.2013.07.01810.1016/j.addr.2013.07.018 ↗
17. 10.1002/dmrr.124810.1002/dmrr.1248 ↗
18. 10.1038/nm158110.1038/nm1581 ↗
19. 10.2337/db06-039310.2337/db06-0393 ↗
20. 10.2337/db06-048410.2337/db06-0484 ↗
21. 10.1038/nm131610.1038/nm1316 ↗
22. 10.1002/mrm.2028210.1002/mrm.20282 ↗
23. 10.1002/mrm.2074710.1002/mrm.20747 ↗
24. 10.2337/db06-048410.2337/db06-0484 ↗
25. 10.1038/nm131610.1038/nm1316 ↗
26. 10.1039/b510982p10.1039/b510982p ↗
27. 10.1002/nbm.108810.1002/nbm.1088 ↗
28. 10.1021/acs.jpcb.6b0047210.1021/acs.jpcb.6b00472 ↗
29. 10.1002/adfm.20140052410.1002/adfm.201400524 ↗
30. 10.1021/acs.chemmater.6b0087710.1021/acs.chemmater.6b00877 ↗
31. 10.1039/C4TB01423E10.1039/C4TB01423E ↗
32. 10.1021/ja206998x10.1021/ja206998x ↗
33. 10.1089/ten.teb.2015.027510.1089/ten.teb.2015.0275 ↗
34. 10.1002/bit.2295910.1002/bit.22959 ↗
35. 10.1002/jbm.b.3266710.1002/jbm.b.32667 ↗
36. 10.1007/BF0040105810.1007/BF00401058 ↗
37. 10.1021/acs.langmuir.5b0296110.1021/acs.langmuir.5b02961 ↗
38. 10.1038/nmeth.208910.1038/nmeth.2089 ↗
39. 10.1016/j.tiv.2012.08.00810.1016/j.tiv.2012.08.008 ↗
40. 10.1002/adhm.20137005710.1002/adhm.201370057 ↗
41. 10.3791/5528010.3791/55280 ↗
42. 10.1186/gb-2006-7-10-r10010.1186/gb-2006-7-10-r100 ↗
43. 10.1021/cm101734410.1021/cm1017344 ↗
44. 10.1002/adfm.20110176610.1002/adfm.201101766 ↗
45. 10.1016/S0167-2991(06)81884-710.1016/S0167-2991(06)81884-7 ↗
46. 10.3389/conf.FBIOE.2016.01.0102110.3389/conf.FBIOE.2016.01.01021 ↗
47. 10.1002/cmmi.26710.1002/cmmi.267 ↗
48. Hoesli, C.Bioprocess Development for the Cell-Based Treatment of Diabetes. Ph.D. Thesis,University of British Columbia,Vancouver, BC, 2010; https://open.library.ubc.ca/cIRcle/collections/24/items/1.0058832.
49. 10.3727/00000000578398328710.3727/000000005783983287 ↗
50. 10.1007/s00125-012-2491-710.1007/s00125-012-2491-7 ↗
51. 10.1002/dmrr.124810.1002/dmrr.1248 ↗
52. 10.1007/s11892-011-0215-x10.1007/s11892-011-0215-x ↗
53. 10.1038/nprot.2011.35210.1038/nprot.2011.352 ↗
54. 10.1002/anie.20100749410.1002/anie.201007494 ↗
55. 10.1007/s00395-008-0710-710.1007/s00395-008-0710-7 ↗
56. 10.1002/nbm.108810.1002/nbm.1088 ↗
57. 10.1002/cmmi.8810.1002/cmmi.88 ↗
58. 10.1148/radiol.1110160810.1148/radiol.11101608 ↗
59. 10.1038/ng1197-32710.1038/ng1197-327 ↗
60. Ishihara H. · Am. J. Physiol.: Endocrinol. Metab. · 1995 · 269 · E897
61. 10.2174/156802661131304000210.2174/1568026611313040002 ↗
62. 10.1038/nature0252010.1038/nature02520 ↗
63. 10.1007/s00125-009-1562-x10.1007/s00125-009-1562-x ↗